Zheng et al. reported that aptamer-based antagonist against RAGE inhibits tumor growth and microvasculature formation in colorectal tumor mice by suppression of the RAGE/NF-κB/VEGF-A signaling [230]. This evidence concerns the gene AGER and colorectal neoplasm.